BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilchrist A, Echeverria SL. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. Front Endocrinol (Lausanne) 2022;13:846310. [PMID: 35399952 DOI: 10.3389/fendo.2022.846310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ge H, Li S, Feng J, Chu H. The Expression of Serum lncRNA MIR17HG in Patients with Multiple Myeloma and Its Clinical Significance. European Journal of Cancer Care 2023;2023:1-7. [DOI: 10.1155/2023/1728909] [Reference Citation Analysis]
2 Sang Y, Li Y, Xu L, Chen J, Li D, Du M. Dysfunction of CCR1(+) decidual macrophages is a potential risk factor in the occurrence of unexplained recurrent pregnancy loss. Front Immunol 2022;13:1045532. [PMID: 36532057 DOI: 10.3389/fimmu.2022.1045532] [Reference Citation Analysis]